Arwan Pharmaceutical Industries, Lebanon

arwanlb.com

Arwan Pharmaceutical Industries,are one of the most advanced biotech manufacturing facilities in the MENA and Africa. Our ultimate goal is to secure quality critical care medicine to all patients who need them. Thus, quality is embedded in each and every step of our operations, from the buildings, machineries, materials, methods and manpower. Empowered by our passion for achievement, strong belief in our capabilities, and the emphasis on performance with integrity, we continue to work according to our motto:

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

ROIVANT GROWS COMPUTATIONAL DRUG DISCOVERY ENGINE WITH ACQUISITION OF SILICON THERAPEUTICS

Roivant Sciences | March 01, 2021

news image

Silicon Therapeutics has assembled an exclusive industry-driving computational physics platform for the in silico design and optimization of small molecule drugs for testing disease targets. The platform incorporates custom strategies dependent on quantum mechanics, sub-atomic elements and measurable thermodynamics to beat basic bottlenecks in drug disclosure projects, for example, anticipating restricting energies and conformational conduct of molecules. Silicon Therapeutics'...

Read More

Views and Analysis

CMIC AND LOKAVANT COLLABORATE TO DEPLOY MACHINE LEARNING-POWERED CLINICAL TRIAL INTELLIGENCE PLATFORM

CMIC | June 25, 2021

news image

CMIC Co., Ltd., a leading Japanese Contract Research Organization (CRO), and Lokavant, a leading clinical trial intelligence company, announced today that they have agreed to use Lokavant's predictive analytics capabilities to assist CMIC's clinical operations. This strategic collaboration, Lokavant Oversight, monitoring, and operational risk management platform, will be implemented throughout CMIC studies. CMIC was the first firm in Japan to provide CRO services, and the ...

Read More

IMPROVED PHARMA CONTINUES TO EXPAND THEIR OFFERINGS TO MEET CUSTOMER NEEDS

Improved Pharma | September 15, 2020

news image

Improved Pharma has expanded their offerings by acquiring S. I. Photonics’ top-of-the-line spectrophotometer, model 440. This model has a high sensitivity, low noise CCD detector that enables the collection of a full spectrum within a second. The power of this instrument is enhanced by the number of accessories and dip probes that permit easy sampling of a variety of materials. The dip probes can be used to monitor reactions in real-time and are especially useful for obtaining quick data d...

Read More

CVS HEAD OF SPECIALTY PHARMACY SEES FUTURE OF HEALTHCARE AT HOME AFTER COVID-19

Medcity news | May 26, 2020

news image

Mail-order prescriptions are nothing new, but pharmacists have turned to a number of other tools to help patients access their prescriptions during the Covid-19 pandemic. The head of CVS Health’s specialty pharmacy strategy, Prem Shah, said he expects to see more patients continue receive healthcare at home after the pandemic ends. Though CVS Health had been building up its arsenal of digital tools before the Covid-19 pandemic, stay-at-home orders forced the pharmacy giant to lean mo...

Read More
news image

Research

ROIVANT GROWS COMPUTATIONAL DRUG DISCOVERY ENGINE WITH ACQUISITION OF SILICON THERAPEUTICS

Roivant Sciences | March 01, 2021

Silicon Therapeutics has assembled an exclusive industry-driving computational physics platform for the in silico design and optimization of small molecule drugs for testing disease targets. The platform incorporates custom strategies dependent on quantum mechanics, sub-atomic elements and measurable thermodynamics to beat basic bottlenecks in drug disclosure projects, for example, anticipating restricting energies and conformational conduct of molecules. Silicon Therapeutics'...

Read More
news image

Views and Analysis

CMIC AND LOKAVANT COLLABORATE TO DEPLOY MACHINE LEARNING-POWERED CLINICAL TRIAL INTELLIGENCE PLATFORM

CMIC | June 25, 2021

CMIC Co., Ltd., a leading Japanese Contract Research Organization (CRO), and Lokavant, a leading clinical trial intelligence company, announced today that they have agreed to use Lokavant's predictive analytics capabilities to assist CMIC's clinical operations. This strategic collaboration, Lokavant Oversight, monitoring, and operational risk management platform, will be implemented throughout CMIC studies. CMIC was the first firm in Japan to provide CRO services, and the ...

Read More
news image

IMPROVED PHARMA CONTINUES TO EXPAND THEIR OFFERINGS TO MEET CUSTOMER NEEDS

Improved Pharma | September 15, 2020

Improved Pharma has expanded their offerings by acquiring S. I. Photonics’ top-of-the-line spectrophotometer, model 440. This model has a high sensitivity, low noise CCD detector that enables the collection of a full spectrum within a second. The power of this instrument is enhanced by the number of accessories and dip probes that permit easy sampling of a variety of materials. The dip probes can be used to monitor reactions in real-time and are especially useful for obtaining quick data d...

Read More
news image

CVS HEAD OF SPECIALTY PHARMACY SEES FUTURE OF HEALTHCARE AT HOME AFTER COVID-19

Medcity news | May 26, 2020

Mail-order prescriptions are nothing new, but pharmacists have turned to a number of other tools to help patients access their prescriptions during the Covid-19 pandemic. The head of CVS Health’s specialty pharmacy strategy, Prem Shah, said he expects to see more patients continue receive healthcare at home after the pandemic ends. Though CVS Health had been building up its arsenal of digital tools before the Covid-19 pandemic, stay-at-home orders forced the pharmacy giant to lean mo...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us